Biotron is preparing a ***detailed briefing package to submit to the FDA during the first quarter of 2022.
Guidance from the FDA will inform the final design of a suitable international trial and will be a key
component of outreach to **potential partners.
**potential partners are what they have been ....
*** they're preparing detailed package in that they're confident to move forward with FDA guidance...
Biotron's Phenomenal Success ..., page-3
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
